Bioengineered tissue and cell therapy products are efficiently cryopreserved with pathogen-inactivated human platelet lysate-based solutions

BACKGROUND: There remains much interest in improving cryopreservation techniques for advanced therapy medicinal products (ATMPs). Recently, human platelet lysate (hPL) has emerged as a promising candidate to replace fetal bovine serum (FBS) as a xeno-free culture supplement for the expansion of huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-López, María, Rosell-Valle, Cristina, Arribas-Arribas, Blanca, Fernández-Muñoz, Beatriz, Jiménez, Rosario, Nogueras, Sonia, García-Delgado, Ana Belén, Campos, Fernando, Santos-González, Mónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079488/
https://www.ncbi.nlm.nih.gov/pubmed/37024935
http://dx.doi.org/10.1186/s13287-023-03300-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079488/
https://www.ncbi.nlm.nih.gov/pubmed/37024935
http://dx.doi.org/10.1186/s13287-023-03300-z

Ejemplares similares